Literature DB >> 18208891

Ehlers-Danlos syndrome and multiple sclerosis: a possible association.

J Vilisaar1, S Harikrishnan, M Suri, C S Constantinescu.   

Abstract

Ehlers-Danlos syndrome (EDS) has various neurological manifestations. Here we present an association of EDS with multiple sclerosis (MS). Four MS patients from a total of 1892 followed up at our MS outpatient clinics had EDS. This frequency suggests 10-11 times increased prevalence of EDS in MS patients compared with the general population (P = 0.02). Suggested implications include a possible causal relationship on a connective tissue level with a higher susceptibility to MS in EDS. Diagnostic and management considerations are important in coexisting MS and EDS. Our patients had relatively florid lesions on brain MRIs and typical course and features of MS.

Entities:  

Mesh:

Year:  2008        PMID: 18208891     DOI: 10.1177/1352458507083187

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  4 in total

1.  Modelling of the dilated sagittal sinuses found in multiple sclerosis suggests increased wall stiffness may be a contributing factor.

Authors:  Grant Alexander Bateman; Jeannette Lechner-Scott; Alexander Robert Bateman
Journal:  Sci Rep       Date:  2022-10-20       Impact factor: 4.996

2.  Coexistence of Ehlers-Danlos syndrome and multiple sclerosis.

Authors:  Hatice Kose Ozlece; Faik Ilik; Nergiz Huseyinoglu
Journal:  Iran J Neurol       Date:  2015-04-04

Review 3.  Association of mast-cell-related conditions with hypermobile syndromes: a review of the literature.

Authors:  Ashley Monaco; Diane Choi; Serife Uzun; Anne Maitland; Bernadette Riley
Journal:  Immunol Res       Date:  2022-04-21       Impact factor: 4.505

4.  Application of immunotherapy for neurological manifestations in hypermobile Ehlers-Danlos syndrome.

Authors:  Manabu Araki; Youwei Lin; Hirohiko Ono; Wakiro Sato; Takashi Yamamura
Journal:  Ther Adv Neurol Disord       Date:  2018-08-18       Impact factor: 6.570

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.